首页|150 L生物反应器规模化扩增狂犬病病毒工艺的建立

150 L生物反应器规模化扩增狂犬病病毒工艺的建立

扫码查看
目的 建立150 L生物反应器大规模培养狂犬病病毒(rabies virus,RABV)的工艺,为后期开发更大规模高密度微载体反应器工艺奠定基础.方法 应用30 L(型号:C30-2)和150 L(型号:VESSEL FERMENTER 300L)生物反应器,以灌流方式培养Vero细胞和CTN-1V株RABV,Cytodex-1微载体浓度20g/L,培养温度36~38 ℃,DO 20%~60%,pH 7.0~7.4,连续13 d收获病毒液,培养过程中取样检测细胞密度、病毒滴度,并对病毒收获液进行无菌和支原体检查及抗原、宿主细胞蛋白(host cell protein,HCP)、牛血清白蛋白(bovine serum albumin,BSA)、DNA残留量检测.结果 30和150 L生物反应器的细胞培养密度均可达1.2×107个/mL以上,在培养过程中各时间点的细胞密度差异均无统计学意义(t=0.225~2.173,P=0.096~0.833).2种规模生物反应器病毒收获液均在感染后6 d达最高病毒滴度(8.5 lgLD50/mL),且差异无统计学意义(t=1.000,P=0.374).2种规模生物反应器病毒收获液的抗原、HCP、BSA和DNA残留量基本一致.结论 可用150 L生物反应器大规模培养RABV,病毒收获液符合《中国药典》三部(2020版)相关标准.
Development of large-scale amplification process of rabies virus in 150 L bioreactor
Objective To develop a large-scale culture process for rabies virus(RABV)in 150 L bioreactor,and lay a foun-dation for the further development of a larger-scale and high-density microcarrier reactor process.Methods Vero cells and RABV strain CTN-1V were cultured in 30 L(model:C30-2)and 150 L(model:VESSEL FERMENTER 300L)bioreactors by perfused culture with 20 g/L Cytodex-1 microcarrier and DO 20%-60%,at culture temperature 36-38 ℃ and pH 7.0-7.4.During the culture process,the cell density and virus titer were measured.The virus culture media was harvested for consecutive 13 d and detected for the sterility,mycoplasma,and the residues of antigen,host cell protein(HCP),bovine serum albumin(BSA)and DNA.Results The density of cultured cells in 30 L and 150 L bioreactors all reached above 1.2 x 107 cell/mL.There was no significant difference in cell density at different time points during the culture(t=0.225-2.173,P=0.096-0.833).The highest virus titer(8.5 lgLD50/mL)was found in the both bioreactors 6 d after infection with no significant difference(t=1.000,P=0.374).The residues of antigen,HCP,BSA and DNA in the virus suspension from the two bioreactors were basically the same.Conclusion 150 L bioreactor can be used for the large-scale culture of RABV,and the harvested virus conformed to the relevant standards in Chinese Pharmacopoeia(Volume Ⅲ,2020 edition).

Rabies virus(RABV)Vero cellsBioreactorMicrocarrier

原国强、郭宏庄、崔晓峰、崔艳霞、孙志华、安文珏、李津、潘若文

展开 >

华兰生物疫苗股份有限公司,河南新乡 453003

河南省生物医药产业研究院,河南新乡 453003

河南省预防型疫苗工程技术研究中心,河南新乡 453003

河南省生物医药(制剂)工程技术研究中心,河南新乡 453003

展开 >

狂犬病病毒 Vero细胞 生物反应器 微载体

河南省先进制造业发展专项郑洛新国家自创区创新引领型产业集群专项

新财预[2018]75号181200211800

2024

中国生物制品学杂志
中华预防医学会,长春生物制品研究所有限责任公司

中国生物制品学杂志

CSTPCD
影响因子:0.417
ISSN:1004-5503
年,卷(期):2024.37(6)